Axogen, Inc. — Director's Dealing 2025

Dec 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-12-08

Reporting Person: Hartley Lindsey Marie (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-08	Common Stock	M	20000	$15.22	Acquired	40763	Direct
2025-12-08	Common Stock	M	5000	$8.20	Acquired	45763	Direct
2025-12-08	Common Stock	S	11533	$31.556	Disposed	34230	Direct
2025-12-08	Common Stock	S	2854	$31.559	Disposed	31376	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-08	Employee Stock Option (right to purchase)	$15.22	M	20000	Disposed	2031-11-01	Common Stock (20000)	Direct
2025-12-08	Employee Stock Option (right to purchase)	$8.20	M	5000	Disposed	2032-03-16	Common Stock (5000)	Direct

Footnotes

F1: All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on November 1, 2025 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on November 1, 2023 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

F2: All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares have vested or will vest each 6 months thereafter.